LINC00960

Across TCGA pan-cancer cohorts, LINC00960 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC00960’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC00960 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00960 is over-expressed in tumor, although a few such as BRCA and KICH show the opposite, repressed pattern.

BRCA, LUAD, and KICH are the cancer types where LINC00960 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00960 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−1.085	<.001	8	view →
LUAD	Male	All	+0.818	.001	4	view →
KICH	Female	II,III,IV	−0.738	.002	3	view →
THCA	All	All	−0.438	.004	3	view →
BLCA	Male	All	+0.890	.049	2	view →
UCEC	All	All	+0.536	.049	2	view →
LIHC	Female	All	+0.534	.014	2	view →
LUSC	All	All	+0.400	.014	2	view →
CHOL	All	All	+1.264	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC00960–BRCA

Open the BRCA breakdown →